When I first created my blog in April 2014, I had to find some material to lead up to my 84 mile walk (at the time, it was a temporary vehicle for the single purpose of raising money for charity). An idea I had probably led to the longer term survival of this blog after people quite liked the descriptions of well known words used in NET parlance. I managed this using an A to Z list over approximately 26 days which was perfect for my timeline.
I gradually renamed those early blog posts and I just noticed that the “F words” survived and this is a remaster!
Enjoy the F words, I’m sure we have all used them many times 🤬😊
Flushing
In early 2010, I had been experiencing mild and infrequent warm feelings in my face and neck and I did notice a slight reddening whilst looking in a mirror when it occurred. It was odd and nothing like I had experienced before. I thought nothing of it, dismissing it as something to do with my age! When I was going through the diagnostic phase some months later, the Consultant who carried out the initial set of tests was interrogating me (literally) for any clues which could help him pin down the nature of my problem (I now know he had evidence of cancer but not the type). I ran through every single niggle and pain I had attributing most of them to age! Just as I thought the barrel was empty, I suddenly remembered about the flushing and mentioned it. Eureka.
Neuroendocrine Cancer is not that common. It can occur in various parts of the body. Some types present with vague symptoms but my type can present with something called ‘Carcinoid Syndrome’ which is even less common despite what you see in patient groups and advocate org websites (only affecting 10% of NETs). This syndrome includes (amongst others) a symptom of facial flushing invoked by the secretion of particular hormones from functioning neuroendocrine tumours. This syndrome which initially worsened, did not come fully under control until after my first major operation some 6 months later. At the time I was keeping my condition private in the workplace which led to some interesting conversations in meetings! Many people thought I had a blood pressure issue!
The treatment for this syndrome is a man-made drug type known generically as a ‘Somatostatin Analogue‘. Basically this drug inhibits the release of excess hormones and therefore reduces the effects of the syndrome (but also has some collateral problems). I now receive a monthly injection of this amazing drug which comprises a rather large needle in the ‘jacksie’.
Read more about NET related flushing by clicking here or on the picture below.
Fibrosis
One of the other strange behaviours of this type of tumour is that they can sometimes cause fibrosis, mostly mesentery and right sided heart, but it also and less commonly includes retroperitoneal fibrosis – again due to the release of excess hormones (mainly serotonin). In my case, the tumours had caused a dense fibrotic retroperitoneal reaction encircling my aorta and intravenous cava (biggest artery and vein in the body respectively) almost blocking the latter. I signed up to the risks for this ‘technically demanding’ phase of my initial operation and two surgeons spent 3 hours (within the 9 hour total time in theatre), dissecting this fibrosis achieving a 270 degree clearance freeing them up and re-establishing normal flow.
Read more about NET related fibrosis by clicking here or on the picture below.
More F words
Ronny Allan’s The A to Z of Neuroendocrine Cancer
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Facebook
Twitter
WordPress
Instagram
Thanks for reading.
Ronny
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma (RASolute 303)
I’ve been wanting to write about this for some time but news in UK today made all the big newspapers. I don’t normally write about other cancers but I’ve been following this one for a while and decided to put pen to paper because it is ground-breaking. Many people will have heard about the new… Read more: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma (RASolute 303) - Can PRRT Be Made More Effective Against NET Liver Metastases? An interesting hybrid approach using 177Lu-DOTATATE
Researchers and clinicians are actively exploring multiple strategies to enhance Peptide Receptor Radionuclide Therapy (PRRT) and make it more effective and personalised for neuroendocrine tumour (NET) patients. Key areas of improvement currently being studied include: Moving PRRT Earlier in Treatment Novel Radioisotopes and Radiosensitizers: Scientists are investigating alternative radioisotopes with different particle ranges and emission… Read more: Can PRRT Be Made More Effective Against NET Liver Metastases? An interesting hybrid approach using 177Lu-DOTATATE - Hey Cancer- it’s been 16 years since my “big surgery”
D Day I was 54 years and 9 months old at diagnosis on 26th July 2010. For the first few months, I had no idea what the outcome would be. What I did know at the time, given the final staging and grading, in addition to the other damage that was accumulated via various tests,… Read more: Hey Cancer- it’s been 16 years since my “big surgery” - Don’t miss these 5 posts on RonnyAllan.NET
Just click on the pictures and read (and hopefully share!) Disclaimer I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or… Read more: Don’t miss these 5 posts on RonnyAllan.NET - Ronny Allan’s Newsletter covering October 2026
Summary of October 2026 on RonnyAllan.NET October was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday. Still a reasonable blog performance – I can’t complain. Still managed to cover 3 new US FDA approvals! I had… Read more: Ronny Allan’s Newsletter covering October 2026 - I made it to 71!
I started doing the “Piss off cancer” or “I made it” series when I got to 65, mainly because I initially thought I wouldn’t make that age. I was 54 years and 9 months old at diagnosis on 26th July 2010. For the first few months, I had no idea what the outcome would be. … Read more: I made it to 71! - Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources?
The title of this blog is in the form of a rhetorical question. Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources? I guess if you ask any patient, the answer would probably be a resounding YES. I also very much guess that many doctors would repeat that answer. … Read more: Neuroendocrine Tumours (NET) – Does rising incidence and prevalence need more research, funding and resources? - Ronny Allan’s Newsletter covering September 2026
Summary of September 2026 on RonnyAllan.NET September was similar to the other months of this year but like July and August, views are down on the previous two months due to 3 weeks of holiday. Still a reasonable blog performance – I can’t complain. Still managed to cover 3 new US FDA approvals! I had… Read more: Ronny Allan’s Newsletter covering September 2026 - Amneal Lanreotide Approved by US FDA
Amneal launches first CGT‑designated U.S. generic lanreotide — what NET patients need to know Amneal has launched the first Competitive Generic Therapy (CGT)‑designated U.S. generic for lanreotide, a major milestone in a market long dominated by Ipsen’s Somatuline® Depot. The product — lanreotide injection 120 mg/0.5 mL in a sterile single‑dose prefilled syringe —… Read more: Amneal Lanreotide Approved by US FDA
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.





Reblogged this on Tony Reynolds Blog.